Showing results (171-180 of 199) with videos related to

Sort By:
Pageof 20
JCI Insight|June 2, 2017
Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesisHoward H Chen, Philip A Waghorn, Lan Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2015
PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic CholangiocarcinomaFrancesco Sabbatino, Vincenzo Villani, Jennifer H Yearley, et al.
Clinical Transplantation|February 9, 2016
Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter studyJessica L Mueller, Lindsay Y King, Kara B Johnson, et al.
Practical Radiation Oncology|June 26, 2018
Liver reirradiation for patients with hepatocellular carcinoma and liver metastasisSusan G R McDuff, Kyla A Remillard, Hui Zheng, et al.
The Oncologist|December 20, 2011
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotypingDarrell R Borger, Kenneth K Tanabe, Kenneth C Fan, et al.
Annals of Surgical Oncology|June 7, 2007
Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysisTimothy M Pawlik, Ana Luiza Gleisner, Todd W Bauer, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Tailored chemical reactivity probes for systemic imaging of aldehydes in fibroproliferative diseasesHua Ma, Iris Y Zhou, Y Iris Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2019
Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall SurvivalNina N Sanford, Jennifer Pursley, Bridget Noe, et al.
Journal of the American Chemical Society|August 17, 2023
Tailored Chemical Reactivity Probes for Systemic Imaging of Aldehydes in Fibroproliferative DiseasesHua Ma, Iris Y Zhou, Y Iris Chen, et al.
The Oncologist|August 7, 2015
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic CholangiocarcinomaLipika Goyal, Aparna Govindan, Rahul A Sheth, et al.
Pageof 20